Use of Chimeric Antigen Receptor Modified T Cells With Extensive Leukemic Myocardial Involvement
Brian Han(Lucile Packard Children's Hospital), Lillian Su(Lucile Packard Children's Hospital), Sneha Ramakrishna(Stanford University), Kara L. Davis(Stanford Medicine), Liora M. Schultz(Stanford Medicine), Saraswati Kache(Lucile Packard Children's Hospital), Raúl Montiel-Esparza(Lucile Packard Children's Hospital), Henry Chubb(Stanford University)
Cited by 2
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock
|Critical Care Medicine|2017|679
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial
|Journal of Clinical Oncology|2022|369
Association of Hypoglycemia, Hyperglycemia, and Glucose Variability With Morbidity and Death in the Pediatric Intensive Care Unit
|PEDIATRICS|2006|359
Ultrarapid Nanopore Genome Sequencing in a Critical Care Setting
|New England Journal of Medicine|2022|224